Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Is Gilead’s new CAR-T overpriced or is payer bureaucracy to blame for slow pickup?
Is Gilead’s new CAR-T overpriced or is payer bureaucracy to blame for slow pickup?
Is Gilead’s new CAR-T overpriced or is payer bureaucracy to blame for slow pickup?
Submitted by
admin
on December 15, 2017 - 11:35pm
Source:
Fierce Pharma
News Tags:
Gilead Sciences
CAR-T
drug pricing
Yescarta
Headline:
Is Gilead’s new CAR-T overpriced or is payer bureaucracy to blame for slow pickup?
Do Not Allow Advertisers to Use My Personal information